AVEO PHARMACEUTICALS INC

AVEO NASDAQ

PennyStock101

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in...

Bullishcharts

Potential trade setup developing. Alert set for break above gap fill at $6.00 Could bring a nice rally with $7.05 as a potential target. Indicators are turning bullish

Samuel12_1980

Can be good chance to set-up an entry above 5 or MA50 Not for any advise Just an idea.

davelar

Trade Safe! Don`t be greedy! Take care and place small trades! If necessary, I will place more long trades at this asset! In my opinion, this stock is at a good opportunity and has good potential for the stock price to go up!

keifer

Hello, What is AVEO? AVEO Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics. News My Thoughts For You There will be a little correction before we see this one moon. Wait for the pullback and monitor the daily TF for direction and 4hr for entry. When you see that the retrace is...

kerkacem

will go up good for bay now

UnknownUnicorn737135

This is what I believe will happen after the FDA accepts the NDA from AVEO. The stock is being artificially held past Reverse Split. There is no reason, after the threat of delisting was eliminated, to be trading below $1.00 pre RS price ($10.00 now) . This algorithm has held this stock down and every spike was shorted to where we are today. Once volume...

PennyStock101

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in...

MrSmallCap

Aveo recently announced that the Tivozanib drug , in its second analysis, showed an improved survival hazard ratio. This penny stock news prompted the company’s stock to fly over 60% from Monday’s opening bell to Tuesday’s premarket high of $1.10. But just as quickly as it jumped, AVEO pulled back aggressively during the last 30 minutes of trading on September...

arielgt9

Long term view of AVEO with a median price of $2.00 until FDA approval of their TIVO-3

SamBarnes

In description

lightrock

AVEO is a biotech with a successful PIII result already. Their PIII was short, 2 years, and the FDA didn't like it even though there was a major win on progression free survival. We get an update in August how the extended PIII is going. To my reasoning, there is > 50% chance this PIII corrects whatever happened last time which appears to have been the result of a...

zhoodtrades

PM for details or to criticize.

kbselander

Where are hedge fund managers pricing their fibonacci's? Quick notes: Fibonacci major resistance at 61.8% - good sign RSI back to par Stochastic crossover below lower threshold MACD may swing back to crossover but need more information. Resistance at 50d moving average Using 1h chart because things are happening VERY QUICKLY on this stock. Psychologically at...

Stircrzy323

MFI under 20 Heikenashi candles and MFI method match perfect MACD starting up wave Stochtastic RSI in oversold (good indication of reversal)

chace222

Inverse H&S looking like a good set up. Sitting on previous support

jack_hartmann

Hello, The chart here really says it all. Tomorrow or next day, AVEO will decide. You can expect a high swing day. Trade as you wish, these are the cues for a little bullish swing. End a swing if it breaks below $1.80 (IMO). Good target would be $2.10 in the short term.

UnknownUnicorn737135

This is a classic example of Wall Street outlasting retail investors. They want ALL of your shares and will take AVEO down to .50cents if necessary . No basis for this at all. Good news doesn't matter. Once they get almost all of the shares then the share price will go up.